secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001562762-22-000242
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q1 2022 net sales $230.5M, up 1.4% YoY; GAAP EPS $0.37, non-GAAP $0.42
--------------------------------------------------------------------------------

- Net sales $230.5M, up 1.4% YoY (1.9% constant currency); U.S. spine sales recovered in March.
- GAAP net income $38.1M (-16% YoY); GAAP diluted EPS $0.37 vs $0.44 in Q1 2021.
- Non-GAAP diluted EPS $0.42 vs $0.49 in Q1 2021, down 13.1% on higher product development and sales costs.
- FY 2022 guidance reaffirmed: net sales $1.025B, non-GAAP diluted EPS $2.10.
- First Excelsius3D imaging units shipped; Enabling Technologies pipeline strong.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000242/0001562762-22-000242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000242/gmed-20220510x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer